Evaluating apoptosis in tumor cells infected with adenovirus expressing p53 tumor suppressor gene. 2007

Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
Laboratory of Gene Therapy, ENH-Research Institute and Department of Medicine, Evanston Hospital, Evanston, IL, USA.

This chapter describes several methods for recognizing apoptosis in tumor cells following infection with a replication-deficient adenovirus expressing the tumor suppressor gene p53. We include cytotoxicity assays and assays of apoptosis, including DNA-nucleosomal DNA fragmentation (DNA laddering), TUNEL, DAPI staining, analysis of the sub-G1 (subdiploid) population, and degradation of poly(ADP-ribose) polymerase (as assayed by Western blot). Although this is not a comprehensive list of protocols to evaluate apoptosis, we believe that these will cover the majority of conditions of apoptosis that may arise. The chapter also describes the characteristics of each technique, including the advantages and disadvantages of each method.

UI MeSH Term Description Entries
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053938 DNA Fragmentation Splitting the DNA into shorter pieces by endonucleolytic DNA CLEAVAGE at multiple sites. It includes the internucleosomal DNA fragmentation, which along with chromatin condensation, are considered to be the hallmarks of APOPTOSIS. DNA Degradation, Apoptotic,Apoptotic DNA Degradation,Fragmentation, DNA
D020287 In Situ Nick-End Labeling An in situ method for detecting areas of DNA which are nicked during APOPTOSIS. Terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 prime OH ends of either single- or double-stranded DNA. The terminal deoxynucleotidyl transferase nick end labeling, or TUNEL, assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA FRAGMENTATION. Nick-End Labeling, In Situ,TUNEL,In Situ Nick End Labeling,In Situ Nick End Labelling,In Situ Nick End-Labeling,In Situ Nick End-Labelling,In Situ Nick-End Labelling,Nick End-Labeling, In Situ,Nick End-Labelling, In Situ,Nick-End Labelling, In Situ,Nick End Labeling, In Situ,Nick End Labelling, In Situ

Related Publications

Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
November 1996, The Journal of cell biology,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
August 2006, Laboratory investigation; a journal of technical methods and pathology,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
January 1996, Cancer gene therapy,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
May 1996, Human gene therapy,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
January 1996, Anticancer research,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
February 1993, Bulletin du cancer,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
April 1996, Nihon rinsho. Japanese journal of clinical medicine,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
August 1990, Nihon rinsho. Japanese journal of clinical medicine,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
March 2001, Cancer research,
Elizabeth Perron, and M Behzad Zafar, and Amanda Pister, and Zhen-Guo Wang, and Jun Tian, and Prem Seth
January 2003, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!